Shivam Chaturvedi
← Back to International Centre for Genetic Engineering and Biotechnology
International Centre for Genetic Engineering and Biotechnology
Shivam Chaturvedi works in Tuberculosis Research and Epidemiology, Immune responses and vaccinations, Infectious Diseases and Tuberculosis, T-cell and B-cell Immunology, Mosquito-borne diseases and control. Recorded institutional associations include International Centre for Genetic Engineering and Biotechnology, International Centre for Genetic Engineering and Biotechnology, All India Institute of Medical Sciences.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
[6]-Gingerol exhibits potent anti-mycobacterial and immunomodulatory activity against tuberculosis
2020 · 71 citationsThe phytochemical bergenin as an adjunct immunotherapy for tuberculosis in mice
2019 · 41 citationsIn Vivo Evaluation of Withania somnifera –Based Indian Traditional Formulation ( Amukkara Choornam ), Against Chikungunya Virus–Induced Morbidity and Arthralgia
2018 · 36 citationsThe 1, 2-ethylenediamine SQ109 protects against tuberculosis by promoting M1 macrophage polarization through the p38 MAPK pathway
2022 · 28 citationsCocculus hirsutus-Derived Phytopharmaceutical Drug Has Potent Anti-dengue Activity
2021 · 27 citationsBerberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis
2023 · 26 citationsSinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity
2023 · 19 citationsWithaferin A Protects against Primary and Recurrent Tuberculosis by Modulating Mycobacterium-Specific Host Immune Responses
2023 · 18 citationsIntranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis
2021 · 15 citationsEstablishment and Comparison of Pathogenicity and Related Neurotropism in Two Age Groups of Immune Competent Mice, C57BL/6J Using an Indian Isolate of Chikungunya Virus (CHIKV)
2019 · 13 citationsSIRT2 inhibition by AGK2 enhances mycobacteria-specific stem cell memory responses by modulating beta-catenin and glycolysis
2023 · 12 citationsBiapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis
2023 · 11 citationsAdjunct Therapy With All-trans-Retinoic Acid Improves Therapeutic Efficacy Through Immunomodulation While Treating Tuberculosis With Antibiotics in Mice
2023 · 7 citationsDepletion of essential mycobacterial gene glmM reduces pathogen survival and induces host-protective immune responses against tuberculosis
2024 · 5 citationsPreliminary study on antiulcer effect of agomelatine and its potentiation with pyridoxine
2017 · 4 citationsRecombinant human scFv antibody fragments against phospholipase A2 from Naja naja and Echis carinatus snake venoms: In vivo neutralization and mechanistic insights
2023 · 3 citationsLy6G+ granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis
2024 · 2 citationsSingle-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses
2024 · 2 citationsLy6G+ granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis
2026 · 1 citationsLy6G+Granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis
2024 · 1 citationsSingle-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses
2025 · 1 citationsAntibodies against Elapidae and Viperidae snake venoms: in vivo neutralization and mechanistic insights
2023 · 0 citationsAuthor response: Ly6G+Granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis
2024 · 0 citationsSingle-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses
2025 · 0 citationsAuthor response: Ly6G+Granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis
2025 · 0 citations
